1315 Capital II is a Venture Capital Fund in Pennsylvania, that has raised $300M from 57 investors, with a minimum investment of $100K, for a fund started in Feb 2018. Data from SEC filing on 13 Feb 2018.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
IRS number
823699113
AUM ?
$302.92M
Address
1315 Capital II
2929 WALNUT STREET
SUITE 1240
PHILADELPHIA
PA 19104
2929 WALNUT STREET
SUITE 1240
PHILADELPHIA
PA 19104
Phone
215-662-1315
Ownership
| Fund structure | AUM | Fund type |
|---|---|---|
| 1315 Capital | $540.71M | |
| 1315 Capital Aiv, LP | $1.02M | Private Equity Fund |
| 1315 Capital II LP | $302.92M | Private Equity Fund |
| 1315 Capital, LP | $236.77M | Private Equity Fund |
Investment data
Securities sold
Number of investors
Regulatory AUM / Assets Under Management
Calendar
19 May 22
31 Dec 22
Financial reports
No filings
Current reports
No filings
Registration and prospectus
Proxies
No filings
Other
No filings
Ownership
SC 13D/A
INTERPACE BIOSCIENCES / 1315 Capital II ownership change
12 Nov 21
SC 13D
Greenbrook TMS / 1315 Capital II ownership change
24 Jun 21
SC 13D/A
INTERPACE BIOSCIENCES / 1315 Capital II ownership change
19 May 21
SC 13D/A
INTERPACE BIOSCIENCES / 1315 Capital II ownership change
21 Jan 21
SC 13D/A
INTERPACE BIOSCIENCES / 1315 Capital II ownership change
30 Apr 20
SC 13D
Interpace Biosciences, Inc.
23 Jan 20
3
Initial statement of insider ownership
23 Jan 20